Isracann Biosciences Inc. (ISCNF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 25, 2025
Isracann Biosciences Market Cap
Isracann Biosciences has a market cap or net worth of $177.00 as of August 8, 2025. Its market cap has decreased by -99.99% in one year.
Market Cap
177.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 18, 2019, Isracann Biosciences's market cap has decreased from 23.84M to 177.00, a decrease of -100.00%. That is a compound annual growth rate of -87.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 177.00 | - |
| Dec 27, 2024 | 177.00 | -99.98% |
| Dec 29, 2023 | 1.06M | -39.75% |
| Dec 30, 2022 | 1.76M | -62.35% |
| Dec 31, 2021 | 4.67M | -82.71% |
| Dec 31, 2020 | 27.03M | -30.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 604.98M |
| Glass House Brands | 478.54M |
| Northwest Biotherapeutics | 365.69M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.51M |